Bayer Vital GmbH — China drug registrations and re-registration deadlines
38 certificates in the NMPA overseas-manufactured drug database (境外生产药品库), snapshot 2026-06-28. Earliest re-registration deadline: 2026-11-30.
| Approval number | Product | Certificate expires | Re-registration deadline (Art. 82) |
|---|---|---|---|
| 国药准字HJ20181160 | Ciprobay 乳酸环丙沙星氯化钠注射液 | 2027-05-30 | 2026-11-30 |
| 国药准字HJ20181161 | Ciprobay 乳酸环丙沙星氯化钠注射液 | 2027-05-30 | 2026-11-30 |
| 国药准字HJ20171327 | Ultravist 碘普罗胺注射液 | 2027-07-17 | 2027-01-17 |
| 国药准字HJ20171328 | Ultravist 碘普罗胺注射液 | 2027-07-17 | 2027-01-17 |
| 国药准字HJ20171329 | Ultravist 碘普罗胺注射液 | 2027-07-17 | 2027-01-17 |
| 国药准字HJ20171330 | Ultravist 碘普罗胺注射液 | 2027-07-17 | 2027-01-17 |
| 国药准字HJ20171331 | Ultravist 碘普罗胺注射液 | 2027-07-17 | 2027-01-17 |
| 国药准字HJ20171332 | Ultravist 碘普罗胺注射液 | 2027-07-17 | 2027-01-17 |
| 国药准字HJ20171333 | Ultravist 碘普罗胺注射液 | 2027-07-17 | 2027-01-17 |
| 国药准字HJ20171334 | Ultravist 碘普罗胺注射液 | 2027-07-17 | 2027-01-17 |
| 国药准字HJ20171335 | Ultravist 碘普罗胺注射液 | 2027-07-17 | 2027-01-17 |
| 国药准字HJ20171336 | Ultravist 碘普罗胺注射液 | 2027-07-17 | 2027-01-17 |
| 国药准字HJ20171337 | Ultravist 碘普罗胺注射液 | 2027-07-17 | 2027-01-17 |
| 国药准字HJ20171338 | Ultravist 碘普罗胺注射液 | 2027-07-17 | 2027-01-17 |
| 国药准字HJ20171339 | Ultravist 碘普罗胺注射液 | 2027-07-17 | 2027-01-17 |
| 国药准字HJ20171340 | Ultravist 碘普罗胺注射液 | 2027-07-17 | 2027-01-17 |
| 国药准字HJ20255008 | Ultravist 碘普罗胺注射液 | 2027-07-17 | 2027-01-17 |
| 国药准字HJ20255009 | Ultravist 碘普罗胺注射液 | 2027-07-17 | 2027-01-17 |
| 国药准字HJ20181189 | Angeliq 雌二醇屈螺酮片 | 2027-08-30 | 2027-02-28 |
| 国药准字HJ20181191 | Angeliq 雌二醇屈螺酮片 | 2027-08-30 | 2027-02-28 |
| 国药准字HJ20180090 | Visanne 地诺孕素片 | 2027-11-15 | 2027-05-15 |
| 国药准字HJ20181184 | Canesten 克霉唑阴道片 | 2027-12-27 | 2027-06-27 |
| 国药准字HJ20181205 | Bayaspirin 阿司匹林维生素C泡腾片 | 2028-04-17 | 2027-10-17 |
| 国药准字HJ20181206 | Bayaspirin 阿司匹林维生素C泡腾片 | 2028-04-17 | 2027-10-17 |
| 国药准字HJ20140513 | Gadovist 钆布醇注射液 | 2028-04-24 | 2027-10-24 |
| 国药准字HJ20140514 | Gadovist 钆布醇注射液 | 2028-04-24 | 2027-10-24 |
| 国药准字HJ20140515 | Gadovist 钆布醇注射液 | 2028-04-24 | 2027-10-24 |
| 国药准字HJ20140516 | Gadovist 钆布醇注射液 | 2028-04-24 | 2027-10-24 |
| 国药准字HJ20140721 | Avelox 盐酸莫西沙星片 | 2028-06-06 | 2027-12-06 |
| 国药准字HJ20140722 | Avelox 盐酸莫西沙星片 | 2028-06-06 | 2027-12-06 |
| 国药准字HJ20140723 | Avelox 盐酸莫西沙星片 | 2028-06-06 | 2027-12-06 |
| 国药准字HJ20140425 | Avelox 盐酸莫西沙星氯化钠注射液 | 2028-09-21 | 2028-03-21 |
| 国药准字HJ20150175 | Primovist 钆塞酸二钠注射液 | 2029-01-14 | 2028-07-14 |
| 国药准字HJ20150178 | Primovist 钆塞酸二钠注射液 | 2029-01-14 | 2028-07-14 |
| 国药准字HJ20160682 | Climen 戊酸雌二醇片/雌二醇环丙孕酮片复合包装 | 2030-01-20 | 2029-07-20 |
| 国药准字HJ20160683 | Climen 戊酸雌二醇片/雌二醇环丙孕酮片复合包装 | 2030-01-20 | 2029-07-20 |
| 国药准字HJ20160678 | Progynova 戊酸雌二醇片 | 2030-01-21 | 2029-07-21 |
| 国药准字HJ20160679 | Progynova 戊酸雌二醇片 | 2030-01-21 | 2029-07-21 |
Under the Provisions for Drug Registration (药品注册管理办法) Art. 82, an application to renew an overseas-manufactured drug registration is filed with the Center for Drug Evaluation no later than 6 months before the certificate expires; the filing line column is that arithmetic applied to the expiry cell. Art. 84(1): a certificate with no application by expiry is not re-registered and is cancelled at expiry. Every figure is taken from the public NMPA database as of 2026-06-28, or computed from it. Registration data changes; the NMPA portal governs. This page states no view on whether any of these products' Domestic Responsible Person (境内责任人) arrangements meet NMPA Announcement No. 137 — that cannot be determined from a public entry.